ADA anticorps (N-Term)
-
- Antigène Voir toutes ADA Anticorps
- ADA (Adenosine Deaminase (ADA))
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris, Rat, Boeuf (Vache), Cobaye, Lapin, Cheval, Chien
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ADA est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- AIAGCREAIK RIAYEFVEMK AKEGVVYVEV RYSPHLLANS KVEPIPWNQA
- Homologie
- Cow: 100%, Dog: 93%, Guinea Pig: 100%, Horse: 86%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%
- Attributs du produit
- This is a rabbit polyclonal antibody against ADA. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human ADA
- Top Product
- Discover our top product ADA Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 363 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease." dans: Neurobiology of disease, Vol. 71, pp. 193-204, (2014) (PubMed).
: "
-
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease." dans: Neurobiology of disease, Vol. 71, pp. 193-204, (2014) (PubMed).
-
- Antigène
- ADA (Adenosine Deaminase (ADA))
- Autre désignation
- ADA (ADA Produits)
- Synonymes
- anticorps ADA-like, anticorps xada, anticorps ADA, anticorps CG11994, anticorps Dmel\\CG11994, anticorps DrosADA, anticorps dADA, anticorps zgc:92028, anticorps adenosine deaminase, anticorps adenosine deaminase S homeolog, anticorps Adenosine deaminase, anticorps ADA, anticorps Ada, anticorps ada.S, anticorps ada
- Sujet
-
ADA is an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins, whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.
Alias Symbols: -
Protein Interaction Partner: UBC, SGCD, PIAS2, TERF2IP, TINF2, ADORA2B, DPP4, NR3C1, DRD1, GRB2, ADORA2A, ADORA1,
Protein Size: 363 - Poids moléculaire
- 41 kDa
- ID gène
- 100
- NCBI Accession
- NM_000022, NP_000013
- UniProt
- P00813
- Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Ribonucleoside Biosynthetic Process
-